# FDA Inspection 1322570 - Cytovance Biologics Inc. - June 17, 2026

Source: https://www.keypedia.com/records/fda_inspections/cytovance-biologics-inc/56631e33-d2ff-4f1a-bdb8-d7a325ef8bd9
Source feed: FDA_Inspections

> FDA Inspection 1322570 for Cytovance Biologics Inc. on June 17, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1322570
- Company Name: Cytovance Biologics Inc.
- Inspection Date: 2026-06-17
- Product Type: Human Drugs
- Office Name: Dallas District Office

## Related Documents

- [FDA Inspection 1089182 - 2019-05-09](https://www.keypedia.com/records/fda_inspections/cytovance-biologics-inc/d6179c1f-7a2a-4cce-9010-40bb23f19661)
- [FDA Inspection 1026556 - 2017-07-20](https://www.keypedia.com/records/fda_inspections/cytovance-biologics-inc/23b9870b-a1d7-4890-bb6f-c476414d80b4)

Company: https://www.keypedia.com/companies/cytovance-biologics-inc/a03c370a-5e60-4617-95b1-521a1d305ac2

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9